Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Long Noncoding RNAs in Cancer Pathways

(2016) Adam M. Schmitt et al.   CANCER CELL

Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer

(2016) Mingwei Chen et al.   CANCER LETTERS

Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

(2016) Jinbo Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells

(2016) Jianfa Li et al.   Oncotarget

Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma

(2015) Liwen Hu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3

(2015) Colleen A. McHugh et al.   NATURE

The emerging role of lncRNAs in cancer

(2015) Maite Huarte   NATURE MEDICINE

Chromatin regulation at the frontier of synthetic biology

(2015) Albert J. Keung et al.   NATURE REVIEWS GENETICS

Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells

(2015) Chengle Zhuang et al.   Oncotarget

HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome

(2014) Aliaksandr A Yarmishyn et al.   BMC GENOMICS

Cancer treatment and survivorship statistics, 2014

(2014) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma

(2014) Ji-hang Yuan et al.   CANCER CELL

PVT1 dependence in cancer with MYC copy-number increase

(2014) Yuen-Yi Tseng et al.   NATURE

Synthetic biology in mammalian cells: next generation research tools and therapeutics

(2014) Florian Lienert et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Urinary biomarkers of bladder cancer: an update and future perspectives

(2013) Charles J Rosser et al.   Biomarkers in Medicine

Role of genomic architecture in the expression dynamics of long noncoding RNAs during differentiation of human neuroblastoma cells

(2013) Arsen O Batagov et al.   BMC Systems Biology

A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions

(2012) Ahmad S. Khalil et al.   CELL

Primary Prevention and Early Detection of Bladder Cancer: Two Main Goals for Urologists

(2012) Maurizio A. Brausi   EUROPEAN UROLOGY

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

(2012) Christopher C Kloss et al.   NATURE BIOTECHNOLOGY

A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group

(2011) Maurizio Brausi et al.   JOURNAL OF UROLOGY

Autoantigen discovery with a synthetic human peptidome

(2011) H Benjamin Larman et al.   NATURE BIOTECHNOLOGY

Engineering the ABA Plant Stress Pathway for Regulation of Induced Proximity

(2011) F.-S. Liang et al.   Science Signaling

Synthetic biology: applications come of age

(2010) Ahmad S. Khalil et al.   NATURE REVIEWS GENETICS

Non-protein coding RNA biomarkers and differential expression in cancers: a review

(2008) Massimo Mallardo et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease

(2008) Alan M. Nieder et al.   JOURNAL OF UROLOGY